List of authorized vaccines and treatments for COVID-19

Product name Company name Product type Status Date of approval Approved for different indication ID
Nuvaxovid XBB.1.5 (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized No 124
COMIRNATY Omicron XBB.1.5 (raxtozinameran) Pfizer Canada ULC Vaccine Authorized No 123
SPIKEVAX XBB.1.5 (andusomeran) Moderna Biopharma Canada Corporation Vaccine Authorized No 122
SPIKEVAX Bivalent Original / Omicron BA.4/5 (elasomeran/ davesomeran) Cancelled by sponsor January 19th, 2024 Moderna Biopharma Canada Corporation Vaccine Authorized No 117
COMIRNATY ORIGINAL/OMICRON BA.1 (tozinameran and riltozinameran) BioNTech Manufacturing GmbH Vaccine Authorized No 116
ACTEMRA (tocilizumab) Hoffmann-La Roche Limited Treatment Authorized No 115
COMIRNATY Original & Omicron BA.4/BA.5 (tozinameran / famtozinameran) BioNTech Manufacturing GmbH Vaccine Authorized No 114
SPIKEVAX Bivalent (elasomeran/ imelasomeran) Cancelled by sponsor January 19th, 2024 Moderna Biopharma Canada Corporation Vaccine Authorized No 111
EVUSHELD (cilgavimab / tixagevimab) AstraZeneca Canada Inc. Treatment Authorized No 109
Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) Cancelled by sponsor March 31st, 2023 Medicago Inc Vaccine Authorized No 106
NUVAXOVID (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized No 104
PAXLOVID (nirmatrelvir / ritonavir) Pfizer Canada ULC Treatment Authorized No 102
Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Authorized By Interim Order No 36
Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Authorized By Interim Order No 34
JCOVDEN (Ad26.COV2.S [recombinant]) Cancelled by sponsor July 26th, 2023. Previously Janssen COVID-19 Vaccine. Janssen Inc Vaccine Authorized By Interim Order No 27
COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order No 29
Vaxzevria (ChAdOx1-S [recombinant]) Cancelled by sponsor December 19th, 2023. Previously Astrazeneca Covid-19 Vaccine. AstraZeneca Canada Inc. Vaccine Authorized By Interim Order No 28
SPIKEVAX (elasomeran) Cancelled by sponsor January 19th, 2024. Previously COVID-19 Vaccine Moderna. Moderna Biopharma Canada Corporation Vaccine Authorized No 15
Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order No 16
Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order No 8
Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized No 9
Nitric oxide (nitric oxide) Sanotize Research & Development Corp. Treatment Under review Under review Yes 76
COVID-19 Vaccine Moderna – Application for Pediatric Use (ages 12-17) (mRNA-1273 SARS-CoV-2) ModernaTX, Inc. Vaccine Under review Under review No 55
Regdanvimab (regdanvimab) Celltrion HealthCare Co Ltd Treatment Under review Under review No 53
Olumiant (baricitinib) Eli Lilly Canada Inc Treatment Under review Under review Yes 39
Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) Medicago Inc Vaccine Under review Under review No 38
Leronlimab (leronlimab) CytoDyn, Inc. Treatment Under review Under review No 35
Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) Eli Lilly Canada Inc Treatment Under review Under review No 32
Novavax COVID-19 Vaccine (NVX-CoV2373) Novavax Inc Vaccine Under review Under review No 31
Favipiravir (favipiravir) Dr Reddys Laboratories Ltd Treatment Under review Under review 17